Zallio F - Search Results

1

Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C.

Corsetti MT, Salvi F, Perticone S, Baraldi A, De Paoli L, Gatto S, Pietrasanta D, Pini M, Primon V, Zallio F, Tonso A, Alvaro MG, Ciravegna G, Levis A. Corsetti MT, et al. Among authors: zallio f. Leuk Res. 2011 Aug;35(8):991-7. doi: 10.1016/j.leukres.2011.02.021. Epub 2011 Apr 6. Leuk Res. 2011. PMID: 21474179 Clinical Trial.

2

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft.

Tarella C, Caracciolo D, Corradini P, Zallio F, Ladetto M, Cuttica A, Rossi G, Novero D, Gavarotti P, Pileri A. Tarella C, et al. Among authors: zallio f. Leukemia. 2000 Apr;14(4):740-7. doi: 10.1038/sj.leu.2401737. Leukemia. 2000. PMID: 10764164

3

Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.

Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A. Zallio F, et al. Clin Transplant. 2013 Jul-Aug;27(4):E491-7. doi: 10.1111/ctr.12172. Epub 2013 Jun 19. Clin Transplant. 2013. PMID: 23781897

4

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma.

Catania G, Zallio F, Monaco F, Corsetti MT, Trincheri N, Bonello L, Mele L, Dallavalle F, Salvi F, Pini M. Catania G, et al. Among authors: zallio f. Leuk Res Rep. 2014 Oct 28;3(2):90-3. doi: 10.1016/j.lrr.2014.09.001. eCollection 2014. Leuk Res Rep. 2014. PMID: 25429355 Free PMC article.

5

The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors.

Busca A, Passera R, Pini M, Zallio F, Dellacasa C, Audisio E, Giaccone L, Maffini E, Costa C, Cavallo R, Bruno B. Busca A, et al. Among authors: zallio f. Am J Hematol. 2015 Jun;90(6):E117-21. doi: 10.1002/ajh.23998. Epub 2015 Apr 1. Am J Hematol. 2015. PMID: 25752810 Free article.

6

Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).

Zallio F, Tamiazzo S, Monagheddu C, Merli F, Ilariucci F, Stelitano C, Liberati AM, Mannina D, Vitolo U, Angelucci E, Rota Scalabrini D, Vallisa D, Bellei M, Bari A, Ciccone G, Salvi F, Levis A. Zallio F, et al. Br J Haematol. 2016 Mar;172(6):879-88. doi: 10.1111/bjh.13904. Epub 2016 Jan 13. Br J Haematol. 2016. PMID: 26763986 Free article. Clinical Trial.

7

A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.

Zallio F, Mazzucco L, Monaco F, Astori MR, Passera R, Drago G, Tamiazzo S, Rapetti M, Dolcino D, Guaschino R, Pini M, Ladetto M. Zallio F, et al. Biol Blood Marrow Transplant. 2016 Sep;22(9):1664-1670. doi: 10.1016/j.bbmt.2016.05.023. Epub 2016 Jun 4. Biol Blood Marrow Transplant. 2016. PMID: 27269196 Free article.

8

Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma.

Giaccone L, Festuccia M, Zallio F, Sorasio R, Brunello L, Maffini E, Dellacasa C, Passera R, Iovino G, Aydin S, Boccadoro M, Vitolo U, Mordini N, Pini M, Busca A, Bruno B. Giaccone L, et al. Among authors: zallio f. Bone Marrow Transplant. 2017 Aug;52(8):1208-1211. doi: 10.1038/bmt.2017.99. Epub 2017 Jun 5. Bone Marrow Transplant. 2017. PMID: 28581461 Clinical Trial. No abstract available.

9

Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case.

Tavarozzi R, Borra T, Catania G, Depaoli L, Corsetti MT, Gaidano V, Limberti G, Ravazzoni F, Mariani N, Zallio F, Nozza P, Ladetto M. Tavarozzi R, et al. Among authors: zallio f. Radiol Case Rep. 2021 Sep 1;16(11):3406-3409. doi: 10.1016/j.radcr.2021.07.087. eCollection 2021 Nov. Radiol Case Rep. 2021. PMID: 34504634 Free PMC article.

10

The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib.

Catania G, Tavarozzi R, Pini GM, Borra T, Gandolfo C, Zacchi G, Pietrasanta D, Monaco F, Zanni M, Lettieri M, Rivela P, Zallio F, Ladetto M. Catania G, et al. Among authors: zallio f. J Basic Clin Physiol Pharmacol. 2023 Apr 12;34(3):401-404. doi: 10.1515/jbcpp-2023-0051. eCollection 2023 May 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 37040263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters